IAIbrahim H. Aboughaleb

Ibrahim H. Aboughaleb

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ibrahim H. Aboughaleb has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comprehensive machine learning models for predicting therapeutic targets in type 2 diabetes utilizing molecular and biochemical features in rats

    by Marwa Matboli, Hiba S. Al-Amodi, Abdelrahman Khaled, Radwa Khaled, Marian M. S. Roushdy, Marwa Ali, Gouda Ibrahim Diab, Mahmoud Fawzy Elnagar, Rasha A. Elmansy, Hagir H. Tahmed, et al.

    Introduction: With the increasing prevalence of type 2 diabetes mellitus (T2DM), there is an urgent need to discover effective therapeutic targets for this complex condition. Coding and non-coding RNAs, with traditional biochemical parameters, have shown promise as viable targets for therapy. Machine learning (ML) techniques have emerged as powerful tools for predicting drug responses.Method: In this study, we developed an ML-based model to identify the most influential features for drug response in the treatment of type 2 diabetes using three medicinal plant-based drugs (Rosavin, Caffeic acid, and Isorhamnetin), and a probiotics drug (Z-biotic), at different doses. A hundred rats were randomly assigned to ten groups, including a normal group, a streptozotocin-induced diabetic group, and eight treated groups. Serum samples were collected for biochemical analysis, while liver tissues (L) and adipose tissues (A) underwent histopathological examination and molecular biomarker extraction using quantitative PCR. Utilizing five machine learning algorithms, we integrated 32 molecular features and 12 biochemical features to select the most predictive targets for each model and the combined model.Results and discussion: Our results indicated that high doses of the selected drugs effectively mitigated liver inflammation, reduced insulin resistance, and improved lipid profiles and renal function biomarkers. The machine learning model identified 13 molecular features, 10 biochemical features, and 20 combined features with an accuracy of 80% and AUC (0.894, 0.93, and 0.896), respectively. This study presents an ML model that accurately identifies effective therapeutic targets implicated in the molecular pathways associated with T2DM pathogenesis.


  • Low-Cost Commercial Integrated Spectral Sensor for Revealing Breast Cancer Margins

    by Mohamed Hisham Fouad Aref, Ibrahim H. Aboughaleb, Abdallah Abdelkader Hussein, Sara Abd El-Ghaffar, Yasser M. Sabry

    Breast malignancy (BM) poses a significant global health challenge, impacting millions worldwide. Precise detection of BM margins is essential in clinical pathology assessments, aiding in surgical margin delineation to effectively reduce recurrence risks. Our proposal involves implementing a cost-effective commercial optical imaging system tailored for distinguishing between malignant and normal tissues using infrared (IR) wavelengths. This system incorporates a low-cost, small and non-invasive spectral sensor (NeoSpectra-Micro) based on Fourier transform IR principles utilizing monolithic MEMS technology, operating within the 1350 to 2500 nm range. Employing this setup, we captured spectral signatures from 30 malignant and 30 normal tissue samples sourced from diverse patient cohorts, analyzing them with detector software. Subsequently, we normalized the data by subtracting the mean value to eliminate offset and scaled it to a range of (-1 to 1) by dividing by the maximum value. These steps enable clear differentiation between normal and BM tissues based solely on pattern, minimizing amplitude effects. Diffused reflected spectra exhibited notable visual differences between BM and normal tissues across three ranges: 1580–1630 nm, 1720–1740 nm, and 2150–2205 nm. Through data analysis, we identified optimal wavelength ranges of 1588 nm, 1722 nm, and 2195 nm, representing maximum differences between normal and tumor tissues. This study underscores the IR-optical sensor's potential as an effective adjunct to clinical pathology. Nonetheless, integration into current protocols necessitates large-scale clinical studies with statistically significant sample sizes.


  • Custom Hyperspectral Imaging System Reveals Unique Spectral Signatures of Heart, Kidney, and Liver Tissues

    by Mohamed Hisham Aref, Sanzhar Korganbayev, Ibrahim H. Aboughaleb, Abdallah Abdelkader Hussein, Ramy Abdlaty, Yasser M. Sabry, Paola Saccomandi, Abou-Bakr M. Youssef


  • Open Access

    Malignant versus normal breast tissue: Optical differentiation exploiting hyperspectral imaging system

    by Mohamed Hisham Aref, Ibrahim H. Aboughaleb, Abdallah Abdelkader Hussein, Ayman Mohammed Farag, Sara Abd El-Ghaffar, Yasser H. El-Sharkawy

    Breast malignancy is a critical problem that severely affects women’s health globally with a high-frequency rate, necessitating fast, effective, and early diagnostic methods. The present study aims to measure the breast tissue’s optical properties by capturing the spectral signatures from malignant and normal breast tissue for therapeutic and diagnostic applications. The optical imaging system incorporates a hyperspectral (HS) camera to capture the spectral signatures for both the malignant and normal breast tissues within 400 ~ 1000 nm. The system was subdivided into two exploratory (reflection/transmission) to measure the tissue’s diffuse reflectance (Rd) and light transmission (Tr), respectively. The study involved 30 breast tissue (normal/tumor) samples from 30 females in the age range of 46 ~ 72 years, who were optically inspected in the visible and near-infrared (VIS-NIR) spectra. Then, the inverse adding doubling (IAD) method for breast tissue characterization and descriptive analysis (T-test) was exploited to verify the significant difference between the various types of breast tissues and select the optimum wavelength. Finally, comparing the study outcome with the histopathological examination to evaluate the system’s effectiveness by calculation (sensitivity, specificity, and accuracy). The average outcome values demonstrated that the optimal spectral bands distinguishing between the normal and the tumor tissues regarding the reflectance approach were 600 ~ 680 nm and 750 ~ 960 nm at the VIS and NIR spectrum, respectively. Then, for the transmission technique, the optimal spectral bands were 560 ~ 590 nm and 760 ~ 810 nm at the VIS and NIR spectra, respectively. Later, the T-test and the IAD verified that the highest Rd values for discrimination were 600 ~ 640 nm and 800 ~ 840 nm at the VIS and NIR spectra, respectively. On the other side, the highest Tr values were 600 ~ 640 nm and 760 ~ 800 nm at the VIS and NIR spectra, respectively. The investigation’s average reading accuracy, sensitivity, and specificity were 85%, 81.88%, and 88.8%, respectively. The experimental trials revealed that the system could identify the optimal wavelength for therapeutic and diagnostic applications through the light interaction behavior of the breast tissue’s optical properties.


  • Open Access

    Prospective study for commercial and low-cost hyperspectral imaging systems to evaluate thermal tissue effect on bovine liver samples

    by Mohamed Hisham Aref, Abdallah Abdelkader Hussein, Abou-Bakr M. Youssef, Ibrahim H. Aboughaleb, Amr A.R. Sharawi, Paola Saccomandi, Yasser H. El-Sharkawy

    Thermal ablation modalities, for example radiofrequency ablation (RFA) and microwave ablation, are intended to prompt controlled tumour removal by raising tissue temperature. However, monitoring the size of the resulting tissue damage during the thermal removal procedures is a challenging task. The objective of this study was to evaluate the observation of RFA on an ex vivo liver sample with both a commercial and a low-cost system to distinguish between the normal and the ablated regions as well as the thermally affected regions. RFA trials were conducted on five different ex vivo normal bovine samples and monitored initially by a custom hyperspectral (HS) camera to measure the diffuse reflectance (Rd) utilising a polychromatic light source (tungsten halogen lamp) within the spectral range 348–950 nm. Next, the light source was replaced with monochromatic LEDs (415, 565 and 660 nm) and a commercial charge-coupled device (CCD) camera was used instead of the HS camera. The system algorithm comprises image enhancement (normalisation and moving average filter) and image segmentation with K-means clustering, combining spectral and spatial information to assess the variable responses to polychromatic light and monochromatic LEDs to highlight the differences in the Rd properties of thermally affected/normal tissue regions. The measured spectral signatures of the various regions, besides the calculation of the standard deviations (δ) between the generated six groups, guided us to select three optimal wavelengths (420, 540 and 660 nm) to discriminate between these various regions. Next, we selected six spectral images to apply the image processing to (at 450, 500, 550, 600, 650 and 700 nm). We noticed that the optimum image is the superimposed spectral images at 550, 600, 650 and 700 nm, which are capable of discriminating between the various regions. Later, we measured Rd with the CCD camera and commercially available monochromatic LED light sources at 415, 565 and 660 nm. Compared to the HS camera results, this system was more capable of identifying the ablated and the thermally affected regions of surface RFA than the side-penetration RFA of the investigated ex vivo liver samples. However, we succeeded in developing a low-cost system that provides satisfactory information to highlight the ablated and thermally affected region to improve the outcome of surgical tumour ablation with much shorter time for image capture and processing compared to the HS system.


  • Transcriptome Spectral Analysis using Hyperspectral Imaging for Hepatocellular Carcinoma Detection

    by Ibrahim H Aboughaleb, M Matboli, Sherif M Shawky, Mohamed Hisham Aref, Yasser H El-Sharkawy

    Hepatocellular carcinoma (HCC) is a noteworthy health problem with a poor diagnosis due to limited detection techniques. Transcriptome studies can be used to classify cancer further away from anatomical location and histopathology. Recent studies demonstrated the novelty of numerous types of specific RNA biomarkers that differentially expressed both the normal liver and the HCC tissues, but those specific types overlapped with the detection of other types of cancers. In this study, total RNA was used to ensure the existence of differences between different cancer types. A multispectral light source (340-1000 nm) interacted with the sample. Multi-wavelengths images were captured using a hyperspectral camera (wavelength 380-1000 nm). The optimum wavelength to discriminate between the normal and HCC samples was selected by calculating the optical properties (transmission, absorption and scattered light). Results showed specific spectral signatures for total RNA within the red-band (633-700 nm) that discriminate HCC from control. The amount of light scattering, transmission and absorption relatively changed due to the variations of size, shape, and concentration of total RNA. The spectral RNA signature that is dependent on the shape and size of total RNA may be utilized as the gold standard for HCC detection.


  • The influence of low- intensity laser irradiation versus hyperbaric oxygen therapy on transcutaneous oxygen tension in chronic diabetic foot ulcers: a controlled randomized trial

    by Amir N. Wadee, Mohamed Hisham Fouad Aref, Ayman A. Nassar, Ibrahim H. Aboughaleb, Siham M. Fahmy

    Background and objective Evaluation of the stage and severity of the chronic diabetic foot ulcer (CDFU) is vital to increase the healing rate and to select the suitable treatment. We aim to assess the influence of low-intensity laser irradiation (LILI) and hyperbaric oxygenation therapy (HBOT) to accelerate the CDFU healing thru the transcutaneous oxygen tension (TcPO2) measurements. Materials and methods Seventy-five diabetic patients (type 2) of both genders, their ages ranged from 40–65 years with CDFUs (duration of ulcer < 6 weeks). All patients were randomly assigned into LILI, HBOT, and the control group. Measurement of TcPO2 using transcutaneous oximetry was performed for all patients once in the baseline and consequently in the second, fourth, and sixth- weeks duration. LILI utilized by a 33-diode cluster contact applicator with output power 1440 mW, energy density (fluency) was adjusted for 4 J/Cm2 at 10 kHz, and for 8 min per session, three times per week for a total of consecutive 6 weeks. HBOT was pressurized up to 2.5 ATA and patients delivered 100% oxygen for 60 min per session for 30 sessions. The Control group received conventional wound care only, twice daily, with saline and apply a new bandage after cleaning. Results MANOVA revealed a statistically insignificant difference in the control group, while statistically significant improvement in both the LILI and HBOT groups. The intergroup comparisons showed an insignificant statistical difference in the pre-test, while highly statistically significant differences for the three post-measures in favor of HBOT and LILI groups. The percentage of improvement of the HBOT group was higher than LILI. Post-hoc test using the least significant difference (LSD) revealed statistically significant differences of HBOT in favor of the LILI group. Conclusion Both LILI and HBOT may be used as adjunctive methods to improve TcPO2 that accelerate healing in CDFUs. HBOT may be favorable in the improvement of TcPO2 than LILI.


  • Open Access

    Novel Approach Exploiting the Hyperspectral Imaging System for Breast Cancer Therapy and Diagnosis

    by Mohamed Aref, Ibrahim H. Aboughaleb, Abou-Bakr Youssef, Yasser El-Sharkawy

    Background: Breast malignant growth is the most widely recognized disease in women in both highly and less developed nations where early detection is vital for life-saving and fast recovery. Recently, Photonic technologies has played a vital role in medical applications. Their satisfactory and viable implementation in therapy and diagnosis requires reliable information on the optical properties of human tissues. This study presents an outline of recent outcomes on the magnitude of breast tissue optical properties.Methods: We established two different system setups utilizing hyperspectral (HS) camera and multiple excitation source lights with wavelength (380~1050 nm) for this investigation. The first setup (Transmission Mode) was applied for light transmission measurement of ex-vivo breast sample. Thereby, we made calculations of sample absorption. The second setup (Reflection Mode) was used for the measurement of breast sample light diffuse reflectance. The outcomes of both setups were used to select the optimum spectral image to differentiate between the normal and tumoral regions in the ex-vivo breast sample by exploring the optical properties spectroscopy in the Near and visible (NIR-VIS) spectrum. Finally, we applied the custom system on the case study technique for breast tumor detection.Results: Experimental investigations results showed that due to the various excitation wavelength light source (380~1050 nm) generates variable depths of penetration depth in the ex-vivo breast sample. Consequently, experimental results of the diffuse reflectance (?d) provide the optimum spectral image at 600 nm for the diagnostic applications. However, the statistical calculation of the normalized signal validated the outcome at wavelength 680 nm. Additionally, we noticed the optimum spectral image for therapy applications at 700 nm by measurement of breast tissue transmission (?) and attenuation absorption (?) calculation. Moreover, the statistical calculation of the normalized signal validated the outcome at wavelength 760 nm.Conclusions: The proposed novel approach successfully provided promising results of the investigated breast sample optical properties in both diagnostic and therapy applications to assist the pathologist and the surgeon. The trail outcomes of the investigated case study were impressive for selecting optimum wavelength for diagnostic and treatment (680, 760 nm), respectively.


  • Hyperspectral imaging for diagnosis and detection of ex-vivo breast cancer

    by Ibrahim H. Aboughaleb, Mohamed Hisham Aref, Yasser H. El-Sharkawy